keyword
https://read.qxmd.com/read/38554375/pituitary-gland-metastasis-of-breast-cancer-presenting-as-diabetes-insipidus-a-case-report
#21
JOURNAL ARTICLE
Asma Ben Abdelkrim, Nouha Ammar, Ghada Saad, Houneida Zaghouani
Metastasis to pituitary gland is a rare condition, and patients are usually asymptomatic. Diabetes insipidus (DI) is the most common presenting symptom, and breast cancer is the most common source of pituitary metastasis (PM). We report a case of PM of breast cancer presenting as DI. A 45-year-old female patient presented to our department with complaints of polyuria and polydipsia. She had a medical history of metastatic breast adenocarcinoma. Laboratory data showed normal fasting plasma glucose level and hypotonic urine...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38552085/severe-hyponatremia-and-diabetes-insipidus-caused-by-low-dose-cyclophosphamide-in-breast-cancer-patients-a-case-report-and-literature-review
#22
JOURNAL ARTICLE
Yanfang Chen, Liye Li, Ruilian Ou, Yulan Wu, Baoying Pan, Linying Luo
RATIONALE: Cyclophosphamide (CTX) is widely used in the treatment of malignancies and autoimmune diseases. Although severe hyponatremia caused by low-dose CTX chemotherapy is uncommon, it can lead to serious complications and even death. PATIENT CONCERNS: A 44-year-old woman with left-sided breast cancer suddenly experienced headaches, disorientation and weakness after receiving low-dose neoadjuvant chemotherapy combined with CTX and doxorubicin. DIAGNOSES: The patient pathology showed invasive breast carcinoma...
March 29, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38543182/metformin-and-breast-cancer-current-findings-and-future-perspectives-from-preclinical-and-clinical-studies
#23
REVIEW
Karen A Corleto, Jenna L Strandmo, Erin D Giles
Over the last several decades, a growing body of research has investigated the potential to repurpose the anti-diabetic drug metformin for breast cancer prevention and/or treatment. Observational studies in the early 2000s demonstrated that patients with diabetes taking metformin had decreased cancer risk, providing the first evidence supporting the potential role of metformin as an anti-cancer agent. Despite substantial efforts, two decades later, the exact mechanisms and clinical efficacy of metformin for breast cancer remain ambiguous...
March 19, 2024: Pharmaceuticals
https://read.qxmd.com/read/38541912/inflammatory-cytokines-associated-with-obesity-type-2-diabetes-and-hypertension-exacerbate-breast-cancer-risk-in-underserved-african-american-and-latin-american-women
#24
JOURNAL ARTICLE
Yanyuan Wu, Eduard Karapetyan, Pranabananda Dutta, Magda Shaheen, Jaydutt V Vadgama
Background: Comorbid chronic diseases, such as obesity, Type-2 Diabetes (T2D), and hypertension (HTN), are major public health issues and highly prevalent among underserved African Americans (AA) and Latin Americans (LA). Elevated inflammatory cytokines are underlying processes in comorbidities (obesity, T2D, and HTN) that could contribute to tumorigenesis and adverse cancer outcomes. Methods: A panel of 19 cytokines was measured by Luminex assay from 570 AA and LA women's serum samples. The comorbidities and breast cancer information were extracted from our existing clinical database...
March 15, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38536933/impact-of-type-2-diabetes-on-complications-after-primary-breast-cancer-surgery-danish-population-based-cohort-study
#25
JOURNAL ARTICLE
Kasper Kjærgaard, Jannik Wheler, Looket Dihge, Peer Christiansen, Signe Borgquist, Deirdre Cronin-Fenton
BACKGROUND: Knowledge is sparse on the impact of type 2 diabetes (T2D) on surgical outcomes after breast cancer surgery. This study investigated the association between T2D and risk of complications after primary breast cancer surgery, and evaluated the biological interaction between T2D and co-morbidities. METHODS: Using the Danish Breast Cancer Group clinical database, a cohort of all Danish women diagnosed with early-stage breast cancer during 1996-2022 was created...
March 2, 2024: British Journal of Surgery
https://read.qxmd.com/read/38536577/can-artificial-intelligence-detect-type-2-diabetes-in-women-by-evaluating-the-pectoral-muscle-on-tomosynthesis-diagnostic-study
#26
JOURNAL ARTICLE
Meltem M Yashar, Ilayda Begum Izci, Fatma Zeynep Gungoren, Abdulkadir A Eren, Ali A Mert, Irmak I Durur-Subasi
OBJECTIVES: This retrospective single-center analysis aimed to evaluate whether artificial intelligence can detect type 2 diabetes mellitus by evaluating the pectoral muscle on digital breast tomosynthesis (DBT). MATERIAL METHOD: An analysis of 11,594 DBT images of 287 consecutive female patients (mean age 60, range 40-77 years) was conducted using convolutional neural networks (EfficientNetB5). The inclusion criterion was left-sided screening images with unsuspicious interpretation who also had a current glycosylated hemoglobin A1c (HBA1c) % value...
March 27, 2024: Insights Into Imaging
https://read.qxmd.com/read/38534815/dendritic-growth-optimization-a-novel-nature-inspired-algorithm-for-real-world-optimization-problems
#27
JOURNAL ARTICLE
Ishaani Priyadarshini
In numerous scientific disciplines and practical applications, addressing optimization challenges is a common imperative. Nature-inspired optimization algorithms represent a highly valuable and pragmatic approach to tackling these complexities. This paper introduces Dendritic Growth Optimization (DGO), a novel algorithm inspired by natural branching patterns. DGO offers a novel solution for intricate optimization problems and demonstrates its efficiency in exploring diverse solution spaces. The algorithm has been extensively tested with a suite of machine learning algorithms, deep learning algorithms, and metaheuristic algorithms, and the results, both before and after optimization, unequivocally support the proposed algorithm's feasibility, effectiveness, and generalizability...
February 21, 2024: Biomimetics
https://read.qxmd.com/read/38530620/sodium-glucose-cotransporter-2-inhibitors-and-cancer-a-systematic-review-and-meta-analysis
#28
JOURNAL ARTICLE
B Xu, B Kang, S Li, S Fan, J Zhou
BACKGROUND: The effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on cancer has yet to be fully elucidated. OBJECTIVE: This systematic review and meta-analysis investigated the effects of SGLT2 inhibitors on cancer. METHODS: We searched the PubMed and ClinicalTrials.gov databases up to July 15, 2023, to identify eligible randomized, double-blind, placebo-controlled trials that lasted at least ≥24 weeks. The primary outcome was the overall cancer incidence, and the secondary outcomes were the incidences of various types of cancer...
March 26, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38529589/metformin-alters-tumor-immune-microenvironment-improving-the-outcomes-of-breast-cancer-patients-with-type-2-diabetes-mellitus
#29
JOURNAL ARTICLE
Satomi Shiba, Michiko Harao, Akira Saito, Masako Sakuragi, Joji Kitayama, Naohiro Sata
This study investigated the clinical effect of metformin on breast cancer patients with preexisting type 2 diabetes mellitus (T2DM). We analyzed 177 patients with T2DM who underwent breast cancer surgery and assessed tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in patients who underwent tumor resection with or without metformin treatment using multiplex immunohistochemistry (IHC). Patients who received metformin either pre- or postoperatively exhibited reduced distant organ recurrence and improved postoperative recurrence-free survival compared to those of patients who did not...
February 23, 2024: Journal of Breast Cancer
https://read.qxmd.com/read/38524964/diabetic-ketoacidosis-with-the-use-of-alpelisib-in-a-patient-with-metastatic-breast-cancer-without-diabetes
#30
Lakshmi Polisetty, Sneha Teresa Selvin, Jia Wei Tan
Diabetic ketoacidosis (DKA) is a life-threatening medical condition. Alpelisib, a new drug used to treat phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha mutated breast cancer, is reported to cause DKA as a rare adverse effect. We present a case of alpelisib-induced DKA in a patient with metastatic breast cancer without diabetes. An 81-year-old female with a history of hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer presented to the emergency room with clinical features and blood work consistent with DKA...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38522690/the-pharmacological-properties-of-gypsophila-eriocalyx-the-endemic-medicinal-plant-of-northern-central-turkey
#31
JOURNAL ARTICLE
Merve İnanir, Esra Uçar, Burak Tüzün, Nuraniye Eruygur, Mehmet Ataş, Hüseyin Aşkın Akpulat
The aim of this study is to evaluate and compare the biological properties of different extracts (methanol, ethanol, and water) obtained from Gypsophila eriocalyx (G. eriocalyx), a medicinal plant traditionally used in Turkey. The components of different extracts were defined using the GC-MS method. The effects of G. eriocalyx extracts on cell proliferation, apoptosis, and cell cycle arrest in MDA-MB-231 breast cancer as well as in vitro antioxidant, enzyme inhibition, and antimicrobial activities were investigated...
March 22, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38520039/metformin-and-other-anti-diabetic-medication-use-and-breast-cancer-incidence-in-the-nurses-health-studies
#32
JOURNAL ARTICLE
Tengteng Wang, Boyang Chai, Wendy Y Chen, Michelle D Holmes, Jennifer Erdrich, Frank B Hu, Bernard A Rosner, Rulla M Tamimi, Walter C Willett, Jae H Kang, A Heather Eliassen
We aimed to examine the association between the use of metformin and other anti-diabetic medications and breast cancer incidence within two large prospective cohort studies. We followed 185,181 women who participated in the Nurses' Health Study (NHS; 1994-2016) and the NHSII (1995-2017), with baseline corresponding to the date metformin was approved for type 2 diabetes (T2D) treatment in the US Information on T2D diagnosis, anti-diabetes medications, and other covariates was self-reported at baseline and repeatedly assessed by follow-up questionnaires every 2 years...
March 22, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38519567/protein-tyrosine-phosphatase-1b-in-metabolic-diseases-and-drug-development
#33
REVIEW
Mirela Delibegović, Sergio Dall'Angelo, Ruta Dekeryte
Protein tyrosine phosphatase 1B (PTP1B), a non-transmembrane phosphatase, has a major role in a variety of signalling pathways, including direct negative regulation of classic insulin and leptin signalling pathways, and is implicated in the pathogenesis of several cardiometabolic diseases and cancers. As such, PTP1B has been a therapeutic target for over two decades, with PTP1B inhibitors identified either from natural sources or developed throughout the years. Some of these inhibitors have reached phase I and/or II clinical trials in humans for the treatment of type 2 diabetes mellitus, obesity and/or metastatic breast cancer...
March 22, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38518977/non-sclerosing-t-cell-and-sclerosing-b-cell-lymphocytic-lobulitis-in-diagnostic-breast-biopsies-clinical-imaging-and-pathologic-features
#34
JOURNAL ARTICLE
Marie-Helene Ngo, Geraldine S Pinkus, Eren D Yeh, Jane E Brock, Stephanie Schulte, Susan C Lester
Lymphocytic lobulitis (LL) is characterized by prominent lymphocytic infiltrates centered on lobules. Sclerosing lymphocytic lobulitis (SCLL) associated with diabetes mellitus (DM) or autoimmune disease (AI) was the first type to be described. Subsequently, non-sclerosing LL (NSCLL) was reported as an incidental finding in prophylactic mastectomies due to high risk germline mutations or a family history of breast cancer. The two types of LL were distinguished by stromal features and a predominant population of B-cells in the former and T-cells in the latter...
March 20, 2024: Human Pathology
https://read.qxmd.com/read/38515856/article-review-brazilin-as-potential-anticancer-agent
#35
REVIEW
Callista Najla Raptania, Syifa Zakia, Alistia Ilmiah Fahira, Riezki Amalia
Brazilin is the main compound in Caesalpinia sappan and Haematoxylum braziletto , which is identified as a homoisoflavonoid based on its molecular structure. These plants are traditionally used as an anti-inflammatory to treat fever, hemorrhage, rheumatism, skin problems, diabetes, and cardiovascular diseases. Recently, brazilin has increased its interest in cancer studies. Several findings have shown that brazilin has cytotoxic effects on colorectal cancer, breast cancer, lung cancer, multiple myeloma, osteosarcoma, cervical cancer, bladder carcinoma, also other cancers, along with numerous facts about its possible mechanisms that will be discussed...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38515400/metabolic-syndrome-and-cardiovascular-disease-in-cancer-survivors
#36
JOURNAL ARTICLE
Kensuke Ueno, Hidehiro Kaneko, Yuta Suzuki, Akira Okada, Satoshi Matsuoka, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Kentaro Kamiya, Junya Ako, Koichi Node, Hideo Yasunaga, Issei Komuro
BACKGROUND: The risk of subsequent cardiovascular disease (CVD) is high in cancer survivors. Although metabolic syndrome is an established risk factor for CVD, its association with cancer survivors has not yet been established. This study aimed to clarify whether metabolic syndrome is associated with subsequent CVD risk in patients with cancer using a nationwide epidemiological dataset. METHODS: We retrospectively analysed 53 510 patients with a history of breast, colorectal, or stomach cancer, which is reportedly a major site for developing cancer in Japan...
March 22, 2024: Journal of Cachexia, Sarcopenia and Muscle
https://read.qxmd.com/read/38514659/factors-associated-with-sedentary-behavior-among-community-dwelling-breast-cancer-survivors-aged-50%C3%A2-years-or-older
#37
JOURNAL ARTICLE
Jae Hyeon Park, Jung Soo Lee, Hyung Seok Nam, Yeo Hyung Kim
Although increased sedentary behavior is associated with poor health outcomes among breast cancer survivors, the factors associated with high sedentary time in community-dwelling breast cancer survivors are unknown. This study aimed to identify factors associated with sedentary behavior in Korean community-dwelling breast cancer survivors aged ≥ 50 years. We included 205 breast cancer survivors from the Korea National Health and Nutrition Examination Survey. Total daily sedentary time was evaluated using questions from the Korean version of the Global Physical Activity Questionnaire...
March 21, 2024: Scientific Reports
https://read.qxmd.com/read/38513346/clinical-description-of-two-cases-of-cowden-syndrome-and-the-implication-regarding-thyroid-cancer
#38
JOURNAL ARTICLE
Stephanie Patrick, Deirdre James
SUMMARY: Thyroid cancer is one of the most common manifestations of Cowden syndrome, yet the syndrome is rare. The incidence of Cowden syndrome is 1 in 200,000. The diagnosis can be made clinically when patients present with a combination of symptoms such as mucocutaneous lesions with a strong personal or family history of thyroid, breast, endometrial, and colorectal cancer. A high index of suspicion is required to provide a clinical diagnosis utilizing major and minor criteria. Once a clinical diagnosis is made, genetic testing for a PTEN mutation, a tumor suppressor gene, is recommended...
January 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38512699/a-systematic-review-of-the-psychosocial-impact-of-endometriosis-before-and-after-treatment
#39
REVIEW
Ashley N Rempert, Trevor H Rempert, Amy Liu, Ana Hernández, Jaime Blanck, James Segars, Bhuchitra Singh
While endometriosis is a common gynecologic disease associated with infertility, the psychosocial impact of endometriosis has not been evaluated against various quality of life (QoL) instruments and compared with other chronic illnesses. We rigorously analyzed the psychosocial burden of endometriosis in adult women and compared standardized and validated QoL scores of women with and without endometriosis, before and following treatment, and against other chronic illnesses. We searched PubMed, PsychINFO Embase, and Cochrane Reviews and ClinicalTrials...
March 21, 2024: Reproductive Sciences
https://read.qxmd.com/read/38510044/alpelisib-related-adverse-events-the-fda-adverse-event-reporting-system-database-faers-pharmacovigilance-study
#40
JOURNAL ARTICLE
Yun Li, Hang Li, Zhongyuan Xiang
BACKGROUND: Alpelisib was approved for treatment of breast cancer. We assessed the safety signals associated with alpelisib by data mining the FDA pharmacovigilance database. METHODS: Data from the second quarter of 2019 to the fourth quarter of 2022 had been retrieved from the FAERS database. Disproportionality analysis by reporting odds ratio were used to evaluate the potential association between adverse events (AEs) and alpelisib. RESULTS: A total of 5,980,090 reports were extracted, 18,149 of them were chosen with alpelisib as the suspected drug...
March 30, 2024: Heliyon
keyword
keyword
33083
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.